Clinical Trial in Canada: Metformin

  • Condition: Fragile X Syndrome
  • Age: Adult 18+, Child
  • Sex: Female, Male

Researchers are testing the effectiveness of Metformin to help improve daily living for individuals with Fragile X syndrome.

The trial further assesses Metformin’s safety, as well as the benefits of the drug, which has been shown to improve the symptoms and difficulties individuals with FXS experience, including: delayed language/cognition, excessive eating, obesity, hypogonadism, and delayed puberty.

About the Study

Who can participate?

Individuals aged 6–35 who have been diagnosed with FXS (and who fit the inclusion/exclusion criteria).

What will happen in the study?

Commit to a four-month study which includes three clinic visits, and five phone calls while taking Metformin orally. Complete various tasks, questionnaires, and examinations by a physician/research team, as well as have blood drawn, as well as urine and stool samples taken.

Will I or my child be paid to complete this study?

Travel expenses will be reimbursed.

Interested in Participating?